Literature DB >> 20554819

Clinical and molecular characteristics of infections with CO2-dependent small-colony variants of Staphylococcus aureus.

Carmen Gómez-González1, Joshi Acosta, Jennifer Villa, Laura Barrado, Francisca Sanz, M Angeles Orellana, Joaquín R Otero, Fernando Chaves.   

Abstract

Most Staphylococcus aureus small-colony variants (SCVs) are auxotrophs for menadione, hemin, or thymidine but rarely for CO(2). We conducted a prospective investigation of all clinical cases of CO(2)-dependent S. aureus during a 3-year period. We found 14 CO(2)-dependent isolates of S. aureus from 14 patients that fulfilled all requirements to be considered SCVs, 9 of which were methicillin resistant. The clinical presentations included four cases of catheter-related bacteremia, one complicated by endocarditis; two deep infections (mediastinitis and spondylodiscitis); four wound infections; two respiratory infections; and two cases of nasal colonization. Pulsed-field gel electrophoresis typing showed that the 14 isolates were distributed into 4 types corresponding to sequence types ST125-agr group II (agrII), ST30-agrIII, ST34-agrIII, and ST45-agrI. An array hybridization technique performed on the 14 CO(2)-dependent isolates and 20 S. aureus isolates with normal phenotype and representing the same sequence types showed that all possessed the enterotoxin gene cluster egc, as well as the genes for alpha-hemolysin and delta-hemolysin; biofilm genes icaA, icaC, and icaD; several microbial surface components recognizing adhesive matrix molecules (MSCRAMM) genes (clfA, clfB, ebh, eno, fib, ebpS, sdrC, and vw); and the isaB gene. Our study confirms the importance of CO(2)-dependent SCVs of S. aureus as significant pathogens. Clinical microbiologists should be aware of this kind of auxotrophy because recovery and identification are challenging and not routine. Further studies are necessary to determine the incidence of CO(2) auxotrophs of S. aureus, the factors that select these strains in the host, and the genetic basis of this type of auxotrophy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20554819      PMCID: PMC2916581          DOI: 10.1128/JCM.00520-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Human endocarditis due to a strain of CO2-dependent penicillin-resistant staphylococcus producing dwarf colonies.

Authors:  W W SPINK; K OSTERBERG; J FINSTAD
Journal:  J Lab Clin Med       Date:  1962-04

Review 2.  Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections.

Authors:  Richard A Proctor; Christof von Eiff; Barbara C Kahl; Karsten Becker; Peter McNamara; Mathias Herrmann; Georg Peters
Journal:  Nat Rev Microbiol       Date:  2006-04       Impact factor: 60.633

3.  Evaluation of two chromogenic agar media for recovery and identification of Staphylococcus aureus small-colony variants.

Authors:  Frank Kipp; Barbara C Kahl; Karsten Becker; Ellen J Baron; Richard A Proctor; Georg Peters; Christof von Eiff
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

4.  The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin-converting bacteriophages.

Authors:  Willem J B van Wamel; Suzan H M Rooijakkers; Maartje Ruyken; Kok P M van Kessel; Jos A G van Strijp
Journal:  J Bacteriol       Date:  2006-02       Impact factor: 3.490

5.  Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis.

Authors:  B Kahl; M Herrmann; A S Everding; H G Koch; K Becker; E Harms; R A Proctor; G Peters
Journal:  J Infect Dis       Date:  1998-04       Impact factor: 5.226

Review 6.  The small colony variant (SCV) concept -- the role of staphylococcal SCVs in persistent infections.

Authors:  Christof von Eiff; Georg Peters; Karsten Becker
Journal:  Injury       Date:  2006-05       Impact factor: 2.586

7.  Epidemiology and clonality of methicillin-resistant and methicillin-susceptible Staphylococcus aureus causing bacteremia in a tertiary-care hospital in Spain.

Authors:  Fernando Chaves; Jesus García-Martínez; Sonia de Miguel; Francisca Sanz; Joaquín R Otero
Journal:  Infect Control Hosp Epidemiol       Date:  2005-02       Impact factor: 3.254

8.  Small colony variants in staphylococcal infections: diagnostic and therapeutic implications.

Authors:  R A Proctor; G Peters
Journal:  Clin Infect Dis       Date:  1998-09       Impact factor: 9.079

9.  Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus.

Authors:  R A Proctor; P van Langevelde; M Kristjansson; J N Maslow; R D Arbeit
Journal:  Clin Infect Dis       Date:  1995-01       Impact factor: 9.079

10.  Human infections caused by thiamine- or menadione-requiring Staphylococcus aureus.

Authors:  J F Acar; F W Goldstein; P Lagrange
Journal:  J Clin Microbiol       Date:  1978-08       Impact factor: 5.948

View more
  13 in total

Review 1.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 2.  Clinical Significance and Pathogenesis of Staphylococcal Small Colony Variants in Persistent Infections.

Authors:  Barbara C Kahl; Karsten Becker; Bettina Löffler
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

3.  Activity of Antibiotics against Staphylococcus aureus in an In Vitro Model of Biofilms in the Context of Cystic Fibrosis: Influence of the Culture Medium.

Authors:  Yvan Diaz Iglesias; Tobias Wilms; Rita Vanbever; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

4.  Functional mgrA Influences Genetic Changes within a Staphylococcus aureus Cell Population over Time.

Authors:  James Lee; Miguel Carda-Diéguez; Miglė Žiemytė; Sarah Vreugde; Clare Cooksley; Heidi A Crosby; Alexander R Horswill; Alex Mira; Peter S Zilm; Stephen P Kidd
Journal:  J Bacteriol       Date:  2022-09-26       Impact factor: 3.476

Review 5.  Molecular Mechanisms of Biofilm Infection: Biofilm Virulence Factors.

Authors:  Priscilla L Phillips; Gregory S Schultz
Journal:  Adv Wound Care (New Rochelle)       Date:  2012-06       Impact factor: 4.730

6.  A Methyl 4-Oxo-4-phenylbut-2-enoate with in Vivo Activity against MRSA that Inhibits MenB in the Bacterial Menaquinone Biosynthesis Pathway.

Authors:  Joe S Matarlo; Yang Lu; Fereidoon Daryaee; Taraneh Daryaee; Bela Ruzsicska; Stephen G Walker; Peter J Tonge
Journal:  ACS Infect Dis       Date:  2016-03-07       Impact factor: 5.084

7.  Phenotype switching is a natural consequence of Staphylococcus aureus replication.

Authors:  Andrew M Edwards
Journal:  J Bacteriol       Date:  2012-08-03       Impact factor: 3.490

8.  Staphylococcus aureus small colony variants show common metabolic features in central metabolism irrespective of the underlying auxotrophism.

Authors:  André Kriegeskorte; Stephanie Grubmüller; Claudia Huber; Barbara C Kahl; Christof von Eiff; Richard A Proctor; Georg Peters; Wolfgang Eisenreich; Karsten Becker
Journal:  Front Cell Infect Microbiol       Date:  2014-10-21       Impact factor: 5.293

9.  The Energy-Coupling Factor Transporter Module EcfAA'T, a Novel Candidate for the Genetic Basis of Fatty Acid-Auxotrophic Small-Colony Variants of Staphylococcus aureus.

Authors:  Nina Schleimer; Ursula Kaspar; Mike Drescher; Jochen Seggewiß; Christof von Eiff; Richard A Proctor; Georg Peters; André Kriegeskorte; Karsten Becker
Journal:  Front Microbiol       Date:  2018-08-14       Impact factor: 5.640

10.  Breast abscess in a case of duct atresia caused by CO2-auxotrophic small colony variants of Staphylococcus aureus: Case report and review of literature.

Authors:  Sayan Bhattacharyya; Nitesh Kumar Jaiswal; Manoj Kumar; Mohammad Aftab Alam Ansari; Asim Sarfraz
Journal:  J Nat Sci Biol Med       Date:  2015 Jul-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.